摘要:
A method is disclosed for synthesizing a zeolite having the framework structure of SSZ-16 using a structure directing agent comprising a dication selected from one or more of 1,1'-(1,4-cyclohexylenedimethylene)bis[1-methylpiperidinium]; 1,1'-(1,4-cyclohexylenedimethylene)bis[1-ethylpiperidinium]; 1,1'-(1,4-cyclohexylenedimethylene)bis[1-methylpyrrolidinium]; and 1,1'-(1,4-cyclohexylenedimethylene)bis[1-ethylpyrrolidinium].
摘要:
Disclosed herein are compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases of aging, or for modulating one or more energy biomarkers, normalizing one or more energy biomarkers, or enhancing one or more energy biomarkers, wherein the compounds are tocopherol quinone derivatives. Further disclosed are compounds, compositions, and methods for treatment of, or prophylaxis against, radiation exposure.
摘要:
Small molecules comprised of azacyclic constrained sphingolipid-like compounds and methods of their synthesis are provided. Formulations and medicaments are also provided that are directed to the treatment of disease, such as, for example, neoplasms, cancers, and other diseases. Therapeutics are also provided containing a therapeutically effective dose of one or more small molecule compounds, present either as pharmaceutically effective salt or in pure form, including, but not limited to, formulations for oral, intravenous, or intramuscular administration.
摘要:
A chemical composition, and formulated products selected from the group consisting of: hair conditioners, fabric softeners, skin moisturizers, shampoos, paper product additives, cosmetics, personal cleansing products, shave preparation products, detergents, non-woven additives, oral care products, and assembled products comprising treated paper or non-woven components, and comprising the chemical composition having the formula: R-C-Z-W wherein R comprises a hydrocarbon, C comprises a cyclic connector; Z comprises an amine; and W comprises a functional group, wherein functional group W is substantially free of oxygen in the instance where the cyclic connector, C, further comprises a carbonyl group.
摘要:
Provided herein are improved processes tor convening C7-amino-substituted tetracyclines to C7-fluoro-substituted tetracyclines, as well as intermediates produced by or used in these processes. In one embodiment, a thermal fluorination method is provided in which a suspension comprising a non-polar organic solvent and a C7-diazo-substituted tetracycline hexafluorophosphate, hexafluoarsenate or hexafluorosilicate salt, or a salt, solvate or combination thereof, is healed to provide a C7-fluoro-substituted tetracycline, or salt, solvate or combination thereof. In another embodiment, a photolytic fluorination is provided in which a solution comprising an ionic liquid and a C-7diazo-substituted tetracycline tetrafluoroborate, hexafluorophosphate, hexafluoroarsenate or hexafluorosilicate salt, or a salt, solvate or combination thereof, is irradiated to provide a C7-fluoro-substituted tetracycline, or salt, solvate or combination thereof.
摘要:
Gegenstand der vorliegenden Erfindung ist die Verwendung stickstoffhaltiger Verbindungen nach der Formel (I) und/oder entsprechender quaternisierter und/oder protonierter Verbindungen zur Herstellung von Polyurethanen, Zusammensetzungen, die diese Verbindungen enthalten sowie Polyurethansysteme, insbesondere Polyurethanschaumstoffe, die unter Verwendung der Verbindungen erhalten wurden.
摘要:
The invention relates to a process for preparing alkanolamines, useful in the removal of CO 2 and/or H 2 S from a CO 2 and/or H 2 S containing gaseous stream, wherein the preparation of the alkanolamines is conducted using specifically selected ionic liquids under specifically selected reaction conditions.
摘要:
The present invention relates to novel GPR 40 agonists of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation.
摘要:
A membrane separation process using a highly fluorinated polymer membrane that selectively permeates water of an aqueous ionic liquid solution to provide dry ionic liquid. Preferably the polymer is a polymer that includes polymerized perfluoro-2,2-dimethyl-1,3-dioxole (PDD). The process is also capable of removing small molecular compounds such as organic solvents that can be present in the solution. This membrane separation process is suitable for drying the aqueous ionic liquid byproduct from precipitating solutions of biomass dissolved in ionic liquid, and is thus instrumental to providing usable lignocellulosic products for energy consumption and other industrial uses in an environmentally benign manner.